Olanzapine versus Aprepitant for Prophylaxis of Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Prospective Randomized Study

Samankaltaisia teoksia

• Olanzapine versus Aprepitant for Prophylaxis of Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Prospective Randomized Study
  Tekijä: Lakshmi D. Gedela, et al.
• Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial
  Tekijä: Yi Cheng, et al.
  Julkaistu: (2022-07-01)
• Effectivity of oral ginger supplementation for chemotherapy induced nausea and vomiting (CINV) in children: A systematic review of clinical trials
  Tekijä: Harri Hardi, et al.
  Julkaistu: (2024-07-01)
• Chemotherapy induced nausea and vomiting may cause anxiety and depression in the family caregivers of patients with cancer
  Tekijä: Xiaozhen Luo, et al.
  Julkaistu: (2023-09-01)
• Olanzapine: The game-changer “antiemetic”
  Tekijä: Manikandan Dhanushkodi
  Julkaistu: (2019-01-01)